GEMS faces scrutiny over costs, governance, and reserves
Parliamentary questions extend from fraud and outsourcing to trustee remuneration and benefit design, while the scheme’s reserves remain below the statutory requirement.
#GovernmentEmployeesMedicalScheme
GEMS suspension puts governance under scrutiny
DENOSA says the lack of disclosure over Stan Moloabi’s suspension raises wider questions about the scheme’s leadership, accountability, and handling of member concerns.
GEMS targets future contribution relief after CMS setback
The scheme says R1.7 billion in projected savings could moderate future increases as it prepares for robust talks with organised labour.
CMS explains why it rejected GEMS’s bid to lower contribution increase
The CMS argues that a 7.5% increase would have weakened GEMS’s financial sustainability and shifted costs to members in future.
CMS rejects GEMS bid to cut 2026 contribution increase as unions demand answers
The regulator has rejected the scheme’s proposal to reduce its weighted average contribution adjustment to 7.5%, leaving the existing 9.5% increase in place.
Bigger, older, and more concentrated: 7 facts reshaping medical schemes
Twenty years of industry data show that medical schemes have become increasingly dependent on scale, investment returns, and strong reserves to remain sustainable.
CMS says GEMS cannot cut 25% reserve requirement
The comment comes amid a growing standoff between organised labour and GEMS after the scheme announced a 9.8% contribution increase for 2026.
BHF and Discovery challenge section 59 report’s conclusions
The Board of Healthcare Funders and Discovery Health say the panel’s final report on FWA investigations rests on flawed methodology and the misinterpretation of data.
